Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancer

Lia Zuylen; JHM (Jan) Schellens; SH (Swan Hoo) Goey; LC Pronk; M Boer-Dennert; Walter Loos; J Ma; Gerrit Stoter; Jaap Verweij

Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancer

Lia Zuylen, JHM (Jan) Schellens, SH (Swan Hoo) Goey, LC Pronk, M Boer-Dennert, Walter Loos, J Ma, Gerrit Stoter, Jaap Verweij

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	361-368
Number of pages	8
Journal	Anti-Cancer Drugs
Volume	10
Publication status	Published - 1999

Research programs

EMC MM-03-86-08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{093212d75be34b6fb6e12436b48d6c29,

title = "Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancer",

author = "Lia Zuylen and Schellens, {JHM (Jan)} and Goey, {SH (Swan Hoo)} and LC Pronk and M Boer-Dennert and Walter Loos and J Ma and Gerrit Stoter and Jaap Verweij",

year = "1999",

language = "Undefined/Unknown",

volume = "10",

pages = "361--368",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "Lippincott Williams & Wilkins",

}

TY - JOUR

T1 - Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancer

AU - Zuylen, Lia

AU - Schellens, JHM (Jan)

AU - Goey, SH (Swan Hoo)

AU - Pronk, LC

AU - Boer-Dennert, M

AU - Loos, Walter

AU - Ma, J

AU - Stoter, Gerrit

AU - Verweij, Jaap

PY - 1999

Y1 - 1999

M3 - Article

SN - 0959-4973

VL - 10

SP - 361

EP - 368

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

ER -